Dianthus Therapeutics (DNTH) Enterprise Value (2017 - 2025)
Dianthus Therapeutics (DNTH) has 7 years of Enterprise Value data on record, last reported at -$401.6 million in Q3 2025.
- For Q3 2025, Enterprise Value fell 42.86% year-over-year to -$401.6 million; the TTM value through Sep 2025 reached -$401.6 million, down 42.86%, while the annual FY2024 figure was -$274.4 million, 58.99% down from the prior year.
- Enterprise Value reached -$401.6 million in Q3 2025 per DNTH's latest filing, down from -$256.1 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$23.2 million in Q1 2023 and bottomed at -$401.6 million in Q3 2025.
- Average Enterprise Value over 4 years is -$204.2 million, with a median of -$189.9 million recorded in 2023.
- Peak YoY movement for Enterprise Value: surged 85.18% in 2023, then plummeted 1524.32% in 2024.
- A 4-year view of Enterprise Value shows it stood at -$75.5 million in 2022, then crashed by 128.62% to -$172.6 million in 2023, then tumbled by 58.99% to -$274.4 million in 2024, then crashed by 46.37% to -$401.6 million in 2025.
- Per Business Quant database, its latest 3 readings for Enterprise Value were -$401.6 million in Q3 2025, -$256.1 million in Q2 2025, and -$262.4 million in Q1 2025.